In orthotopic mouse GBM xenografts, treatment with radiolabelled EphA3 monoclonal antibody (mAb) IIIA4 blocked tumour growth, supporting the utility of EphA3 as a therapeutic target in GBM [58]. Here, EPHA3 is linked to neoplasm.